Charles Schwab Investment Management Inc. Buys 15,008 Shares of Astera Labs, Inc. (NASDAQ:ALAB)

Charles Schwab Investment Management Inc. increased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 12.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,472 shares of the company’s stock after buying an additional 15,008 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.08% of Astera Labs worth $17,546,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Steward Partners Investment Advisory LLC lifted its stake in Astera Labs by 99.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after purchasing an additional 99 shares in the last quarter. SBI Securities Co. Ltd. acquired a new stake in shares of Astera Labs in the fourth quarter valued at approximately $1,661,000. US Bancorp DE raised its stake in Astera Labs by 627.4% during the 4th quarter. US Bancorp DE now owns 6,350 shares of the company’s stock valued at $841,000 after acquiring an additional 5,477 shares during the last quarter. Versor Investments LP purchased a new position in Astera Labs during the fourth quarter worth about $451,000. Finally, Proficio Capital Partners LLC lifted its position in shares of Astera Labs by 1,008.3% during the 4th quarter. Proficio Capital Partners LLC now owns 235,364 shares of the company’s stock valued at $31,174,000 after acquiring an additional 214,128 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Michael E. Hurlston sold 2,500 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total value of $230,200.00. Following the completion of the transaction, the director now owns 91,794 shares of the company’s stock, valued at $8,452,391.52. The trade was a 2.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Michael Truett Tate sold 125,800 shares of Astera Labs stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $82.53, for a total transaction of $10,382,274.00. Following the completion of the transaction, the chief financial officer now directly owns 244,242 shares in the company, valued at $20,157,292.26. This trade represents a 34.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 570,990 shares of company stock worth $50,242,702.

Astera Labs Trading Up 0.1 %

ALAB stock opened at $68.97 on Friday. The stock has a market cap of $11.18 billion and a PE ratio of -39.87. The stock has a 50-day moving average price of $92.41 and a two-hundred day moving average price of $88.70. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. On average, analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of research analyst reports. Northland Capmk raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. Morgan Stanley cut their price target on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 28th. Stifel Nicolaus increased their price objective on shares of Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a report on Monday, January 6th. Craig Hallum boosted their price target on shares of Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a report on Tuesday, February 11th. Finally, Barclays lifted their target price on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $112.77.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.